Skip to content
HowShorted

SELLAS Life Sciences Group, Inc. short interest in 2023

In 2023, SELLAS Life Sciences Group, Inc.'s disclosed short interest ran from 5.84% of shares outstanding on 13 Jan 2023 to 14.75% on 29 Dec 2023, a change of +8.91 percentage points. The year's high was 14.75% on 29 Dec 2023 and its low 3.60% on 15 Sep 2023, averaging 6.52% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.64 days on 15 Aug 2023. Full history: SELLAS Life Sciences Group, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SELLAS Life Sciences Group, Inc. in 2023

2023 in figures

Start of year
5.84% (13 Jan 2023)
End of year
14.75% (29 Dec 2023)
Change
+8.91 pp
High
14.75% (29 Dec 2023)
Low
3.60% (15 Sep 2023)
Average
6.52%
Highest days to cover
10.64 (15 Aug 2023)
SEC filings marked
9

Every report in 2023

SELLAS Life Sciences Group, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20235.84%9.91
31 Jan 20235.69%5.86
15 Feb 20235.81%6.22
28 Feb 20236.25%1.00results (8-K)
15 Mar 20234.30%1.89
31 Mar 20233.88%3.2710-K filed, results (8-K)
14 Apr 20234.16%3.74
28 Apr 20234.25%5.79
15 May 20234.43%5.8210-Q filed, results (8-K)
31 May 20234.21%7.65
15 Jun 20233.95%9.97
30 Jun 20234.10%8.29
14 Jul 20234.06%7.33
31 Jul 20234.17%8.49
15 Aug 20234.00%10.6410-Q filed, results (8-K)
31 Aug 20233.98%10.63
15 Sep 20233.60%8.16
29 Sep 20233.83%5.92
13 Oct 20237.19%1.86
31 Oct 202310.76%5.31
15 Nov 202314.29%4.8410-Q filed, results (8-K)
30 Nov 202314.38%6.91
15 Dec 202314.52%9.70
29 Dec 202314.75%5.80

See also: SELLAS Life Sciences Group, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.